
Opinion|Videos|October 14, 2024
Challenges Associated With Dravet Syndrome Treatment
Author(s)M. Scott Perry, MD
Key Takeaways
- Dravet syndrome's genetic basis and seizure variability complicate treatment, necessitating personalized approaches and regular monitoring.
- Escalation therapy requires careful evaluation of drug efficacy, side effects, and patient-specific factors to ensure optimal outcomes.
Scott Perry, MD, discusses how treatment challenges in Dravet syndrome necessitate careful monitoring by health care providers, who must consider factors such as individual patient response, adverse effect profiles, drug interactions, and the potential need for escalation therapy, to optimize seizure control and overall patient outcomes.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- What are some treatment challenges associated with Dravet syndrome? (
Strzelczyk, 2022 )- Please describe the different considerations HCPs must take into account when monitoring Dravet syndrome treatment to ensure optimal utilization of escalation therapy options.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Cladribine Tablets Show Ability to Improve or Stabilize Cognitive Function in Patients With Relapsing Multiple Sclerosis
2
Cladribine Maintains Efficacy, Safety Profile in Older Patients With Multiple Sclerosis
3
Myelin Protective Small Molecule Lucid-MS Shows Promising Early-Stage Data in Healthy Volunteers
4
CD40L Inhibitor Frexalimab Enters Phase 3 FREXITE Trial of Non-Relapsing Secondary Progressive Multiple Sclerosis
5











